← SynDRA
KN-93
SynDRA canonical compound SYN1968790 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CAMK2A |
|---|
| Mechanism of action | calcium/calmodulin dependent protein kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- calcium/calmodulin dependent protein kinase inhibitor
Cross-references
Synonyms
- KN 93
- KN93
- Methoxybenzene-sulfonamide
- C26H29ClN2O4S
- CHEMBL155333
- (E)-N-(2-(((3-(4-Chlorophenyl)allyl)(methyl)amino)methyl)phenyl)-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide
- 2-(N-(2-Hydroxyethyl)-N-(4-methoxybenzenesulfonyl))amino-N-(4-chlorocinnamyl)-N-methylbenzylamine
- N-(2-(((3-(4-Chlorophenyl)-2-propenyl)methylamino)methyl)phenyl)-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide
- Benzenesulfonamide, N-(2-(((3-(4-chlorophenyl)-2-propenyl)methylamino)methyl)ph
Look up KN-93 in the interactive SynDRA portal →